InspireMD to Participate in Upcoming Bank of America Securities 2026 Global Healthcare Conference
InspireMD (Nasdaq: NSPR) will present at the Bank of America Securities 2026 Global Healthcare Conference on Wednesday, May 13, 2026 at 4:20 pm PT.
Rhea-AI Summary
InspireMD (Nasdaq: NSPR) will present at the Bank of America Securities 2026 Global Healthcare Conference on Wednesday, May 13, 2026 at 4:20 pm PT. A live audio webcast and archived recording will be available via the company’s Investors page at the provided investor website link.
Positive
- None.
Negative
- None.
Key Figures
- Conference date
- May 13, 2026
- Bank of America Securities 2026 Global Healthcare Conference presentation
- Presentation time
- 4:20 pm PT
- Scheduled time for InspireMD’s conference presentation
- ATM program size
- $75,000,000
- Equity Distribution Agreement with BTIG under 424B5 filed Apr 3, 2026
- Q1 2026 revenue
- $3.4 million
- First quarter 2026 results reported May 4, 2026
- Q1 2026 net loss
- $13.7 million
- Net loss for first quarter 2026
Historical Context
-
Reported strong revenue growth but ongoing net loss and recall reserves.
-
Voluntary U.S. recall of CGuard Prime 135 cm and withdrawal of 2026 guidance.
-
FDA IDE approval for CGUARDIANS III pivotal study of SwitchGuard system.
-
Announcement of timing for release of Q1 2026 financial results and call.
-
Planned presentation at the 25th Annual Needham Virtual Healthcare Conference.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
carotid stent medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
MIAMI, May 06, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced plans to present at the upcoming Bank of America Securities 2026 Global Healthcare Conference on Wednesday, May 13th at 4:20 pm Pacific Time (PT).
A live audio webcast and an archive of the recording will be available through the Investors page of InspireMD’s corporate website at https://investors.inspiremd.com.
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on the Company’s website. For more information, please visit www.inspiremd.com.
Investor Contacts:
Jeff Warren
LifeSci Advisors
jwarren@lifesciadvisors.com
investor-relations@inspiremd.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.